Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Endologix, Inc. (LELGX) to Present at the ROTH Capital Partners 24th Annual Conference

Endologix develops, manufactures, markets, and sells innovative medical devices for the treatment of aortic disorders. Endologix primarily focuses on its endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA), a weakening of the wall of the aorta. In worst cases, the AAA may enlarge and, if left untreated, becomes increasingly susceptible to rupture, making it a leading killer in the United States. For more information visit the company’s Web site at www.endologix.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *